Arcus Biosciences, Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Arcus Biosciences, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Arcus Biosciences, Inc. Return On Equity for the quarter ending September 30, 2024 was -45.6 %, a 8.86% increase year-over-year.
  • Arcus Biosciences, Inc. annual Return On Equity for 2023 was -57.2 %, a 55.2% decline from 2022.
  • Arcus Biosciences, Inc. annual Return On Equity for 2022 was -36.8 %, a 561% decline from 2021.
  • Arcus Biosciences, Inc. annual Return On Equity for 2021 was 7.99 %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -57.2 -20.3 -55.2% Jan 1, 2023 Dec 31, 2023
2022 -36.8 -44.8 -561% Jan 1, 2022 Dec 31, 2022
2021 7.99 +38.4 Jan 1, 2021 Dec 31, 2021
2020 -30.5 +14.2 +31.8% Jan 1, 2020 Dec 31, 2020
2019 -44.6 -24.8 -125% Jan 1, 2019 Dec 31, 2019
2018 -19.8 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.